AI assistant
INSMED Inc — Director's Dealing 2021
Mar 18, 2021
30150_dirs_2021-03-18_1c9d1d40-ba7e-4002-b042-d701f6044ab2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-03-16
Reporting Person: Lewis William (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-16 | Common Stock | M | 50000 | $3.4 | Acquired | 229608 | Direct |
| 2021-03-16 | Common Stock | S | 23639 | $35.65 | Disposed | 205969 | Direct |
| 2021-03-16 | Common Stock | S | 26061 | $36.66 | Disposed | 179908 | Direct |
| 2021-03-16 | Common Stock | S | 300 | $37.18 | Disposed | 179608 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-16 | Stock Option (right to buy) | $3.4 | M | 50000 | Disposed | 2022-09-10 | Common Stock (50000) | Direct |
Footnotes
F1: The transactions reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2: This is the weighted average sales price representing 23,639 shares sold at prices ranging from $35.18 to $36.13 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: This is the weighted average sales price representing 26,061 shares sold at prices ranging from $36.15 to $37.04 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F4: This is the weighted average sales price representing 300 shares sold at prices ranging from $37.05 to $37.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F5: The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.